The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,514,760 in first-year total cost, median $6,257,380.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-U (A1)]2
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Minority PDX Development and Trial Center: Baylor College of Medicine and MD Anderson Cancer Center Collaboration on Mechanistic Studies to Dissect and Combat Health Disparities in Cancer1U54CA233223-01 | KAOCHAR, SALMA | BAYLOR COLLEGE OF MEDICINE, TX | $6,353,982 | ZCA1 |
| 2018 | University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities1U54CA233306-01 | CARVAJAL CARMONA, LUIS GUILLERMOCHEN, MOON SHAO-CHUANGPAN, CHONG-XIAN | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $6,160,778 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.